Clinical trial

Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis

NCT00517933

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-08-01

PhasePHASE3

Study timeline

Study start (unknown)2007-08-01Date precision: month

Registry last updated2015-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Fibrosisunresolved

Hypertension, Pulmonaryunresolved

Interventions

Sildenafil CitrateDRUG · verified · RxNorm: sildenafil citrate

PlaceboOTHER

Sponsors & collaborators

Duke Universitylead sponsor

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Pfizercollaborator

Mapped research locations

New YorkNew York, United States1 ChicagoIllinois, United States1 Los AngelesCalifornia, United States1 AtlantaGeorgia, United States1 NashvilleTennessee, United States1 San FranciscoCalifornia, United States1 SeattleWashington, United States1 BirminghamAlabama, United States1 DurhamNorth Carolina, United States1 DenverColorado, United States1 Ann ArborMichigan, United States1 RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00517933 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.